Recent research by Tara and her team was selected for interview by journalists from USA for a special edition of Nature Outlook on CRISPr. Nature Outlooks tackle topics of scientific, clinical and societal interest, giving a comprehensive picture of the current state of knowledge and the hottest areas of research. This work was selected for presentation at ARVO 2015, EMBO 2015 and Cold Spring Harbor Laboratories Conference 2015. Indeed Tara’s research was the first in the world to evidence SNP derived PAM gene silencing in vivo and is currently under review with Nature Communications.
Read the full interview here.
